Please use this identifier to cite or link to this item: http://223.31.159.10:8080/jspui/handle/123456789/331
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Kamal-
dc.contributor.authorYadav, Saurabh-
dc.contributor.authorPurayannur, Savithri-
dc.contributor.authorVerma, Praveen K.-
dc.date.accessioned2015-11-05T09:51:09Z-
dc.date.available2015-11-05T09:51:09Z-
dc.date.issued2013-
dc.identifier.citationMol. Biotechnol., 54(2): 133-140en_US
dc.identifier.issn1559-0305-
dc.identifier.urihttp://172.16.0.77:8080/jspui/handle/123456789/331-
dc.descriptionAccepted date: 04 May 2012en_US
dc.description.abstractThe Gateway(®) recombination technology has revolutionized the method of gene cloning for functional analyses and high-throughput ORFeome projects. In general, Gateway cloning is highly efficient because after LR recombination and bacterial transformation, only cells containing the recombinant destination clone are selected on an antibiotic selection plate. However, when the antibiotic resistance gene for bacterial selection is the same in the entry and destination vectors, the direct selection of recombinant destination clones on an antibiotic plate is difficult. Here, we demonstrate an efficient and comprehensive approach to obtain positive destination clones directly on an antibiotic selection plate in this situation. The strategy involves polymerase chain reaction (PCR)-mediated amplification of the entry clone using entry vector-specific primers that bind outside the attL sequences and the subsequent use of this purified PCR product for LR recombination with the destination vector. Our results suggest that cloning of linear DNA fragments into circular destination vectors through LR recombination is an efficient method for inserts up to 7 kb in size. Using this approach, the yield of colony PCR positive destination clones was 100 % for genes of various sizes tested in our experiments.en_US
dc.description.sponsorshipThis work is supported partially by research grant provided by Department of Biotechnology, Government of India for Next Generation Challenge Programe on Chickpea Genomics project (Sanction No. BT/PR12919/AGR/02/676/2009), and National Institute of Plant Genome Research (N.I.P.G.R.), New Delhi. K.K. acknowledges NIPGR for Postdoctoral fellowship. We thank Kamil Onder (Paracelsus Private Medical University Salzburg, Austria) and Tsuyoshi Nakagawa (Shimane University, Japan) for pBD-gate1 and pGWB441 destination vectors, respectively.en_US
dc.language.isoen_USen_US
dc.publisherSpringeren_US
dc.subjectGateway cloningen_US
dc.subjectKanamycin selectionen_US
dc.subjectEntry vectoren_US
dc.subjectDestination vectoren_US
dc.subjectLR recombinationen_US
dc.titleAn alternative approach in Gateway ® cloning when the bacterial antibiotic selection cassettes of the entry clone and destination vector are the sameen_US
dc.typeArticleen_US
dc.identifier.officialurlhttp://link.springer.com/article/10.1007%2Fs12033-012-9549-0en_US
dc.identifier.doi10.1007/s12033-012-9549-0en_US
Appears in Collections:Institutional Publications

Files in This Item:
File Description SizeFormat 
Verma PK_2013_3.pdf
  Restricted Access
853.88 kBAdobe PDFView/Open Request a copy


Items in IR@NIPGR are protected by copyright, with all rights reserved, unless otherwise indicated.